Literature DB >> 34840982

Diagnosis of Chronic Infection at Total Hip Arthroplasty Revision Is a Question of Definition.

Sebastian Philipp Boelch1, Kilian Rüeckl1, Laura Elisa Streck1, Viktoria Szewczykowski1, Manuel Weißenberger1, Axel Jakuscheit1, Maximilian Rudert1.   

Abstract

PURPOSE: Contradicting definitions of periprosthetic joint infection (PJI) are in use. Joint aspiration is performed before total hip arthroplasty (THA) revision. This study investigated the influence of PJI definition on PJI prevalence at THA revision. Test quality of prerevision aspiration was evaluated for the different PJI definitions.
METHODS: 256 THA revisions were retrospectively classified to be infected or not infected. Classification was performed according to the 4 different definitions proposed by the Musculoskeletal Infection Society (MSIS), the Infectious Diseases Society of America (IDSA), the International Consensus Meeting (ICM), and the European Bone and Joint Infection Society (EBJIS). Only chronic PJIs were included.
RESULTS: PJI prevalence at revision significantly correlated with the applied PJI definition (p = 0.01, Cramer's V = 0.093). PJI prevalence was 20.7% for the MSIS, 25.4% for the ICM, 28.1% for the IDSA, and 32.0% for the EBJIS definition. For synovial fluid white blood cell count, the best ROC-AUC for predicting PJI was 0.953 in combination with the MSIS definition.
CONCLUSION: PJI definition significantly influences the rate of diagnosed PJIs at THA revision. Synovial fluid white blood cell count is a reliable means to rule out PJI. In cases with a borderline high synovial white blood cell count before THA revision as the only sign of chronic PJI, an extended diagnostic work-up should be considered.
Copyright © 2021 Sebastian Philipp Boelch et al.

Entities:  

Mesh:

Year:  2021        PMID: 34840982      PMCID: PMC8626185          DOI: 10.1155/2021/8442435

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Introduction

Periprosthetic joint infection (PJI) has become a rare complication in primary total hip arthroplasty (THA), occurring in 0.2% to 2.0% [1, 2]. However, because the absolute number of THA revision is increasing, the number of PJIs will increase, too [3]. Since the eminent review on PJIs by Zimmerli et al. in 2004 [4], a number of PJI definitions have been proposed. The Musculoskeletal Infection Society (MSIS) was the first to publish a standard for the definition of PJI in 2011. This definition inaugurated the major criteria of PJI, which were the presence of a sinus tract or repeated pathogen isolation from the periprosthetic surrounding [5]. This definition was followed by a guideline published by the Infectious Diseases Society of America (IDSA) in 2012. Herein, pathologic periprosthetic tissue results and purulence were added to the pathognomonic major criteria of PJI [6]. The International Consensus Meeting (ICM), which was held in 2013 and in 2018, introduced a likelihood scale calculated from the presence of major and also of minor criteria [7]. The European Bone and Joint Infection Society (EBJIS) lately added the synovial white blood cell count (sWBC) as a major PJI criterion in their proposal for a PJI definition [8]. But still, the consensus on what defines PJI is weak [7]. Particularly, the biofilm-associated subtypes, i.e., chronic PJIs, are causing trouble being defined. Additionally, the clinical presentation of chronic infection typically is subliminal [7, 8]. Prerevision recognition of chronic PJI is of high medical, legal, and economical significance, because the treatment concepts of septic and aseptic THA failures are dissimilar. Thus, diagnostic algorithms advocate prerevision aspiration to exclude chronic PJI as an unrecognized cause of THA failure before revision [9-11]. Therefore, this study aimes to invistigate whether the choice of PJI definition influences the prevalence of PJIs at THA revision. Additionally, the test quality of prerevision aspiration was evaluated for the different PJI definitions.

2. Materials and Methods

2.1. Patients

Approval for this retrospective study was given by the institution's ethics committee (Reference number 2016072801). 349 cases that underwent THA revision with collection of at least 2 tissue samples for culturing and with anteceding joint aspiration between January 2012 and December 2019 were retrospectively identified. 22 cases were excluded due to a punctio sicca and 18 because the indwelling prosthesis was an interim spacer. Further, 47 patients with symptoms lasting less than 3 weeks and 6 patients that received antibiotics within 14 days before aspiration were excluded. Thus, 256 THA revision cases were included in this study.

2.2. Evaluation of Periprosthetic Joint Infection

At the study institution, PJI is evaluated on the basis of patients' history, clinical findings as well as blood infection parameters, imaging studies, and polymerase chain reaction-based means in particular situations. THAs with a chronic history of complaints are aspirated by default to rule out PJI before proceeding to revision surgery. Synovial fluid is cultivated for at least 14 days. With the remaining aspirate, synovial fluid white blood cell count (sWBC) was performed. During revision surgery, 2 to 5 tissue specimens are collected and cultured for 14 days. Tissue samples are taken and evaluated for failure reason by a pathology specialist.

2.3. Definitions of Periprosthetic Joint Infection

All 256 revised THAs were retrospectively classified as PJI or no PJI. Classification was performed according to the definitions issued by the MSIS in 2011, by the IDSA in 2013, and by the EBJIS in 2021. Since the ICM discriminates an acute from a chronic situation, only the criteria for the chronic PJI were taken into account. For the MSIS criteria, PJI can be either confirmed, if at least one of the major criteria or if at least 4 of the 6 minor criteria are present. In contrast, the ICM definition comprises a scoring system based on major and minor criteria. PJI is defined by either at least one major criterion or if the scoring of the minor criteria sums up to at least 6 points. With the IDSA and the EBJIS criteria, PJI is confirmed by the presence of at least one major criterion. Table 1 summarizes the applied definitions.
Table 1

PJI definitions sorted by publishing organization.

MSIS [5]IDSA [6]ICM [7] (chronic)EBJIS [8]
Major criteria Major criteria Major criteria Major criteria
Sinus tractSinus tractSinus tractSinus tract
Pathogen isolated from at least two samples from synovia or periprosthetic tissueSame pathogen isolated from at least two samples from synovia or periprosthetic tissueSame pathogen isolated from at least two samples from the prosthesis' surroundingSame pathogen isolated from at least two samples from the prosthesis' surrounding
Minor criteria (i) ESR > 30 mm/h and CRP >1 mg/dl(ii) Elevated sWBC (>3000 cells/mm3)(iii) Elevated PMN percentage in sWBC(iv) Presence of purulence(v) One pathogen isolated from prosthesis surrounding(vi) 5 neutrophils/HPF in histologyGrowth of a virulent pathogen in a single specimen Minor criteria (i) CRP > 1 mg/dl or D − dimer > 860 μg/l.(ii) ESR > 30 mm/h(iii) sWBC > 3000/μl or LE strip (++) or positive alpha defensin test(iv) >70% PMN in sWBC(v) Single positive culture(vi) Positive histology(vii) Presence of purulencePositive immunoassay or lateral flow assay
Presence of purulencesWBC > 3000/μl
>80% PMN
Acute inflammation at histologic examination of periprosthetic tissuePresence of ≥5 neutrophils in ≥5 HPFs or presence of visible microorganisms

∗For retrospective classification, infection was defined as judged by the pathologist. CRP: C-reactive protein; sWBC: synovial white blood cell count; PMN: polymorphonuclear neutrophils in synovia; HPF: high-power filed; LE: leucocyte esterase.

2.4. Diagnostic Value of Prerevision Joint Aspiration

Synovial fluid culture results and sWBC results from prerevision aspiration were compared with the 4 different PJI definitions. Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were calculated in comparison to the applied definition. For sWBC, the test quality was additionally evaluated.

2.5. Statistics

Data is displayed as mean and range. Correlation between PJI definitions and PJI rate was evaluated with the chi2 test. Significance was set at p < 0.05. The effect power was calculated with Cramer's V. Receiver operating characteristic (ROC) curves were plotted for sWBC depending on the applied definition. The area under the curve (ROC-AUC) analysis was performed to quantify the quality of the test. Statistics were performed with SPSS 28 (SPSS Inc., USA).

3. Results

3.1. Patients

52.0% (N = 133) of the 256 revisions were performed in female patients. Mean age was 69 years (20-90); the mean duration from aspiration to revision was 51 days (0-289). 63.6% (N = 163) had no previous revision, 30.9% (N = 79) had 1 to 3 previous revisions, and 5.5% (N = 14) had more than 3 previous revisions. Mean duration from previous surgery to revision was 95.6 months (2.2-406.6). 73.8% (N = 189) were cementless implants. At least one of the implant components was loose in 75.4% (N = 193). Mean C-reactive protein level at revision was 1.5 mg/dl (0.0-27.2).

3.2. Rate of PJI according to the Applied Definitions

Selection of PJI definition significantly correlated with the PJI rate (p = 0.03). However, the correlation was low (Cramer's V = 0.093). The distribution of PJI rates according to the applied definitions is shown in Table 2.
Table 2

Distribution of PJI according to the applied definition (N = 256). The rate for repeated pathogen detection, single pathogen detection, no pathogen detection based on prerevision aspiration, and intraoperative tissue samples is shown.

MSIS % (N)ICM % (N)IDSA % (N)EBJIS % (N)
PJI rate20.7 (53)25.4 (65)28.1 (72)32.0 (82)
Rate of repeated pathogen detection98.1 (52)75.4 (49)68.1 (49)57.0 (49)
Rate of single pathogen detection1.9 (1)13.9 (9)13.9 (10)19.8 (17)
Rate of PJI without pathogen detection0.0 (0)10.8 (7)18.1 (13)19.5 (16)

MSIS: Musculoskeletal Infection Society; ICM: International Consensus Meeting; IDSA: Infectious Diseases Society of America; EBJIS: European Bone and Joint Infection Society.

3.3. Diagnostic Value of Joint Aspiration before Revision

Table 3 shows sensitivity, specificity, PPV, and NPV for synovia fluid cultures from prerevision aspiration according to the applied PJI definition.
Table 3

Sensitivity, specificity, and positive and negative predictive values for synovia fluid cultures from prerevision joint aspiration according to the applied PJI definition in %.

MSISICMIDSAEBJIS
Sensitivity67.958.551.452.4
Specificity96.697.496.7100.0
PPV83.788.486.1100.0
NPV92.087.383.681.2

MSIS: Musculoskeletal Infection Society; ICM: International Consensus Meeting; IDSA: Infectious Diseases Society of America; EBJIS: European Bone and Joint Infection Society; PPV: positive predictive value; NPV: negative predictive value.

SWBC from prerevision aspiration was performed in 46.5% of the included revision cases (119/256). Table 4 shows sensitivity, specificity, PPV, and NPV for sWBC according to the applied PJI definition.
Table 4

Sensitivity, specificity, and positive and negative predictive values for sWBC from preoperative joint aspiration according to the applied PJI definition in %.

MSISICMIDSAEBJIS
Sensitivity90.581.570.061.5
Specificity95.298.096.7100.0
PPV82.695.791.3100.0
NPV97.995.891.785.4

MSIS: Musculoskeletal Infection Society; ICM: International Consensus Meeting; IDSA: Infectious Diseases Society of America; EBJIS: European Bone and Joint Infection Society; PPV: positive predictive value; NPV: negative predictive value.

ROC-AUC analysis showed the best quality for sWBC as a predictor for PJI in combination with the MSIS definition (AUC = 0.953) followed by the combination with the ICM definition (AUC = 0.900) as depicted in Figure 1.
Figure 1

ROC-AUC analysis for the sWBC in comparison to the applied definitions. MSIS: Musculoskeletal Infection Society; ICM: International Consensus Meeting; IDSA: Infectious Diseases Society of America; EBJIS: European Bone and Joint Infection Society.

Because the IDSA definition is the only one that does not include the sWBC, the sensitivity and specificity calculated by ROC are exemplified. Figure 2 shows that the sensitivity looses 3 percentage points from a sWBC of 650 cells/mm3 to 3450 cells/mm3 but specificity increases by 19.8 percentage points.
Figure 2

Sensitivity (continuous spline) and specificity (dotted spline) depicted as decimal (y-axis) in dependence of sWBC (x-axis). The vertical dotted line marks a sWBC of 650 cells/mm3 and the continuous line a sWBC of 3450 cells/mm3.

4. Discussion

The consensus on the definition of PJI is weak [7]. Several different PJI definitions have been established. Under this aspect, the current study investigated whether the selection of PJI definition influences the prevalence of chronic PJIs at THA revision. We found that PJI prevalence significantly correlated with the applied definition. Thus, chronic infection at THA revision is a question of definition. This conclusion needs to be considered whenever treatment decisions are made. Although the correlation between PJI definition and PJI prevalence was significant, the association was low. All 53 revision cases classified as PJI by the MSIS definition were consistently classified a PJI by all of the 3 other definition systems. In contrast, no case was classified PJI exclusively by the ICM criteria. Further, 2 cases were classified PJI exclusively by the IDSA because purulence was the only indicator of PJI. Finally, 2 cases were classified PJI exclusively by the EBJIS because a sWBC > 3000 cells/mm3 was the only indicator of PJI. In these doubtful cases, treatment decision should include balancing probabilities carefully. This applies particularly for chronic PJIs, where the gold standard treatment is the two-stage exchange [12]. The 90-day mortality of the two-stage exchange has been reported to be 4%, and up to 10.5% of the patients are unfit to proceed to the second stage [13, 14]. Thus, the invasiveness necessary for infection eradication should be weighed against the risk of overtreatment. Currently, joint aspiration with sWBC is considered the most important pillar to exclude PJI before revision [15, 16]. Irrespectively of the applied definition, sWBC proved to be of higher diagnostic value than synovial fluid culture. Comparable results are described in the review by Ahmad et al. In their study, sWBC had a sensitivity of 88% while synovial fluid culture had a sensitivity of only 72% [17]. However, the authors also stated a 95% confidence interval ranging from 0.81 to 0.90 for sWBC sensitivity and highlighted the issue of a lacking gold standard [17]. The current study compared the sWBC sensitivities when the 4 most important PJI definitions are used. The ROC-AUC analysis showed that the sWBC provides the best test quality in combination with the MSIS definition. At a cut-off of 3000 cells/mm3, the sensitivity was 90.5%. A trend towards lower cut-off values, for instance 1500 cells/mm3, can currently be observed in the literature [18-20]. However, Figure 2 shows that improving the sensitivity by lowering cut-off values goes along with enlarging the risk of overtreatment due to inadequate specificity. The herein presented data underline that even for chronic PJI, the sWBC with a cut-off of 3000 cells/mm3 should be appreciated a reliable threshold to rule out infection before THA revision. Nevertheless, sWBC may rather be considered a “guide value” rather than a “cut-off value.” If borderline high sWBC values are the only sign of infection, additional work-up to confirm PJI should be considered before proceeding to a two-stage exchange. Due to its retrospective design, there are limitations to this study. Intraoperative tissue samples for histologic work-up were inconsistently evaluated. Rather than describing the sole number of neutrophilic granulocytes per high-power field (HPF), histologic findings were documented as to be confirmative for PJI or were classified according to Krenn et al. [21]. However, just as the definition of PJI shows a dynamic evolution so does histologic evaluation: The MSIS highlighted the fact that “histologic examination (...) may be operator dependent” but recommended a cut-off of 5 neutrophils per HPF [5]. The IDSA leaves the histologic definition up to the pathologist [6]. Last, while the ICM 2018 summary discusses the thresholds of at least 5 neutrophils in contrast to 10 neutrophils in each of 5 HPFs, the EBJIS criteria demand at least 23 neutrophils per 10 HPFs [16]. A further limitation is that sWBC was available in only 46.5% of the 256 included revision cases. However, within these selected cases, PJI prevalence was 17.7% for the MSIS, 21.8% for the ICM, 24.4% for the IDSA, and 31.1% for the EBJIS definition, respectively. Thus, prevalence of the cases with available sWBC was similar to the overall PJI prevalence. While at the study institution, synovia fluid samples were preferably used for pathogen identification before revision in the past, joint aspiration with sWBC now is performed to exclude PJI.

5. Conclusion

Orthopedic surgeons need to be aware that their choice of PJI definition significantly influences the rate of diagnosed PJIs at THA revision. Synovial white blood cell count is a reliable means to rule out PJI. In cases with a borderline high synovial white blood cell count before THA revision as the only sign of chronic PJI, an extended diagnostic work-up should be considered.
  21 in total

Review 1.  Pathogenesis and treatment concepts of orthopaedic biofilm infections.

Authors:  Werner Zimmerli; Claus Moser
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-15

Review 2.  [Implant-associated infections - Diagnostics].

Authors:  N Renz; M Müller; C Perka; A Trampuz
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

3.  Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: When is the best time to perform the second stage?

Authors:  Ines Vielgut; Patrick Sadoghi; Matthias Wolf; Lukas Holzer; Andreas Leithner; Gerold Schwantzer; Rudolf Poolman; Bernhard Frankl; Mathias Glehr
Journal:  Int Orthop       Date:  2015-04-14       Impact factor: 3.075

Review 4.  Prosthetic-joint infections.

Authors:  Werner Zimmerli; Andrej Trampuz; Peter E Ochsner
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

Review 5.  [Diagnostic Algorithm for Failure Analysis of Painful Total Hip Arthroplasties].

Authors:  B Fink; R Lass
Journal:  Z Orthop Unfall       Date:  2016-10-11       Impact factor: 0.923

6.  The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years.

Authors:  Manuel Weißenberger; Alexander Klug; Yves Gramlich; Maximilian Rudert; Philipp Drees; Reinhard Hoffmann; Karl Philipp Kutzner
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-07-15       Impact factor: 4.342

7.  Alpha Defensin Lateral Flow Test for Diagnosis of Periprosthetic Joint Infection: Not a Screening but a Confirmatory Test.

Authors:  Nora Renz; Katsiaryna Yermak; Carsten Perka; Andrej Trampuz
Journal:  J Bone Joint Surg Am       Date:  2018-05-02       Impact factor: 5.284

8.  The EBJIS definition of periprosthetic joint infection.

Authors:  Martin McNally; Ricardo Sousa; Marjan Wouthuyzen-Bakker; Antonia F Chen; Alex Soriano; H Charles Vogely; Martin Clauss; Carlos A Higuera; Rihard Trebše
Journal:  Bone Joint J       Date:  2021-01       Impact factor: 5.082

9.  The Preoperative Microbial Detection is No Prerequisite for the Indication of Septic Revision in Cases of Suspected Periprosthetic Joint Infection.

Authors:  Daniel Karczewski; Tobias Winkler; Carsten Perka; Michael Müller
Journal:  Biomed Res Int       Date:  2018-06-21       Impact factor: 3.411

10.  Inferior performance of established and novel serum inflammatory markers in diagnosing periprosthetic joint infections.

Authors:  Irene Katharina Sigmund; Johannes Holinka; Kevin Staats; Florian Sevelda; Richard Lass; Bernd Kubista; Alexander Giurea; Reinhard Windhager
Journal:  Int Orthop       Date:  2020-11-27       Impact factor: 3.075

View more
  1 in total

1.  Laboratory-Reported Normal Value Ranges Should Not Be Used to Diagnose Periprosthetic Joint Infection.

Authors:  Salvador A Forte; Joseph A D'Alonzo; Zachary Wells; Brett Levine; Stephen Sizer; Carl Deirmengian
Journal:  Cureus       Date:  2022-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.